Elisabeth Tuisl

404 total citations
21 papers, 348 citations indexed

About

Elisabeth Tuisl is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, Elisabeth Tuisl has authored 21 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Physiology and 5 papers in Pharmacology. Recurrent topics in Elisabeth Tuisl's work include Adenosine and Purinergic Signaling (7 papers), Receptor Mechanisms and Signaling (7 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Elisabeth Tuisl is often cited by papers focused on Adenosine and Purinergic Signaling (7 papers), Receptor Mechanisms and Signaling (7 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Elisabeth Tuisl collaborates with scholars based in Austria. Elisabeth Tuisl's co-authors include Wolfgang Schütz, Michael Freissmuth, Christian Nanoff, W. Sch�tz, O. Kraupp, Günter Steurer, Norbert Kolassa, Liselotte Adler-Kastner, Herbert Plass and Peter Krivanek and has published in prestigious journals such as Biochemical Journal, British Journal of Pharmacology and Biochemical Pharmacology.

In The Last Decade

Elisabeth Tuisl

21 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabeth Tuisl Austria 10 179 165 91 73 71 21 348
W. Sch�tz Austria 10 201 1.1× 106 0.6× 77 0.8× 87 1.2× 51 0.7× 15 327
Wendy Hope Australia 14 175 1.0× 109 0.7× 59 0.6× 191 2.6× 106 1.5× 23 462
N J Welsh United Kingdom 11 149 0.8× 29 0.2× 58 0.6× 117 1.6× 58 0.8× 15 357
Reid W. von Borstel United States 10 156 0.9× 64 0.4× 57 0.6× 86 1.2× 41 0.6× 14 357
Chongxue Zhu United States 11 251 1.4× 121 0.7× 126 1.4× 57 0.8× 82 1.2× 12 449
Tamio Iwamoto Japan 13 177 1.0× 102 0.6× 248 2.7× 79 1.1× 90 1.3× 32 553
A. Fenner Germany 8 108 0.6× 37 0.2× 68 0.7× 23 0.3× 27 0.4× 17 357
Kooichi Saida United States 9 211 1.2× 16 0.1× 96 1.1× 85 1.2× 131 1.8× 20 317
Guihua Tu China 14 142 0.8× 199 1.2× 97 1.1× 73 1.0× 120 1.7× 18 472
V. N. Serebryakov Russia 10 240 1.3× 19 0.1× 149 1.6× 117 1.6× 136 1.9× 15 371

Countries citing papers authored by Elisabeth Tuisl

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Tuisl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Tuisl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Tuisl more than expected).

Fields of papers citing papers by Elisabeth Tuisl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Tuisl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Tuisl. The network helps show where Elisabeth Tuisl may publish in the future.

Co-authorship network of co-authors of Elisabeth Tuisl

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Tuisl. A scholar is included among the top collaborators of Elisabeth Tuisl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Tuisl. Elisabeth Tuisl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Schütz, Wolfgang, et al.. (1991). Bioequivalence between two furosemide-spironolactone formulations: A pharmacokinetic and pharmacodynamic approach. Current Medical Research and Opinion. 12(7). 450–458. 1 indexed citations
3.
Nanoff, Christian, Michael Freissmuth, Elisabeth Tuisl, & Wolfgang Schütz. (1990). P2‐, but not P1‐purinoceptors mediate formation of 1,4,5‐inositol trisphosphate and its metabolites via a pertussis toxin‐insensitive pathway in the rat renal cortex. British Journal of Pharmacology. 100(1). 63–68. 33 indexed citations
4.
Nanoff, Christian, Michael Freissmuth, Elisabeth Tuisl, & Wolfgang Schütz. (1989). A Different Desensitization Pattern of Cardiac β-Adrenoceptor Subtypes by Prolonged In Vivo Infusion of Isoprenaline. Journal of Cardiovascular Pharmacology. 13(2). 198–203. 51 indexed citations
5.
Freissmuth, Michael, et al.. (1987). Stimulation of adenylate cyclase activity via A2-adenosine receptors in isolated tubules of the rabbit renal cortex. European Journal of Pharmacology. 138(1). 137–140. 12 indexed citations
6.
Freissmuth, Michael, et al.. (1987). Glomeruli and microvessels of the rabbit kidney contain both A1- and A2-adenosine receptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 335(4). 438–444. 37 indexed citations
7.
Sch�tz, W., et al.. (1986). Cardiac sarcolemmal purity is essential for the verification of adenylate cyclase inhibition via A1-adenosine receptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 333(2). 156–162. 17 indexed citations
8.
Freissmuth, Michael, et al.. (1986). Alterations of the Glomerular β-Adrenoceptor-Linked Adenylate Cyclase System in Perinephritis Hypertension. Journal of Cardiovascular Pharmacology. 8(1). 60–66. 12 indexed citations
9.
Schütz, Wolfgang, Günter Steurer, Elisabeth Tuisl, & O. Kraupp. (1984). The Cardiac and Brain Micro vessel Adenylate Cyclase System in Deoxycorticosterone Acetate-Hypertensive Rats. Journal of Cardiovascular Pharmacology. 6(2). 325–330. 6 indexed citations
10.
Schütz, Wolfgang, Günter Steurer, Elisabeth Tuisl, & Herbert Plass. (1984). Phosphorylated adenosine derivatives as low-affinity adenosine-receptor agonists. Methodological implications for the adenylate cyclase assay. Biochemical Journal. 220(1). 207–212. 6 indexed citations
11.
Freissmuth, Michael, et al.. (1984). Interaction of the antihypertensive drug urapidil with cardiac β-adrenoceptors in vitro. European Journal of Pharmacology. 104(1-2). 169–172. 13 indexed citations
12.
Tuisl, Elisabeth, et al.. (1983). Theoretical analysis of adenosine release from cardiac tissue as influenced by transport inhibitors. Canadian Journal of Physiology and Pharmacology. 61(8). 946–949. 2 indexed citations
13.
Schütz, Wolfgang, Günter Steurer, & Elisabeth Tuisl. (1982). Functional identification of adenylate cyclase-coupled adenosine receptors in rat brain microvessels. European Journal of Pharmacology. 85(2). 177–184. 47 indexed citations
14.
Sch�tz, W., Elisabeth Tuisl, & O. Kraupp. (1982). Adenosine receptor agonists: Binding and adenylate cyclase stimulation in rat liver plasma membranes. Naunyn-Schmiedeberg s Archives of Pharmacology. 319(1). 34–39. 42 indexed citations
15.
Schütz, Wolfgang & Elisabeth Tuisl. (1981). Evidence against adenylate cyclase-coupled adenosine receptors in the guinea pig heart. European Journal of Pharmacology. 76(2-3). 285–288. 36 indexed citations
16.
Wiener, H., Peter Krivanek, Elisabeth Tuisl, & Norbert Kolassa. (1980). Induction of drug metabolism in the rat by taglutimide, a sedative-hypnotic glutarimide derivative. European Journal of Drug Metabolism and Pharmacokinetics. 5(2). 93–97. 7 indexed citations
17.
Kolassa, Norbert, Elisabeth Tuisl, & O. Kraupp. (1978). Effects of the carboxylesterase inhibitor bis-(p-nitrophenyl)-phosphate on elimination of hexobendine. Biochemical Pharmacology. 27(18). 2269–2273. 3 indexed citations
18.
Kolassa, Norbert, Elisabeth Tuisl, & O. Kraupp. (1977). Effects of the carboxylesterase inhibitor bis-(p-nitrophenyl)-phosphate on disposition and metabolism of hexobendine. Biochemical Pharmacology. 26(3). 223–228. 8 indexed citations
19.
Kraupp, O., et al.. (1966). [Effect of hexabendin on oxygen consumption, energetics and substrate metabolism of the heart. II. Studies with intravenously administered single doses].. PubMed. 16(6). 692–7. 9 indexed citations
20.
Kraupp, O., et al.. (1966). [The effect of hexabendin on oxygen consumption, energeties and substrate metabolism of the heart. II. Studies with intravenous infusions].. PubMed. 16(6). 697–705. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. Sch�tz Breakdown of academic impact, for papers by Wendy Hope Breakdown of academic impact, for papers by N J Welsh Breakdown of academic impact, for papers by Reid W. von Borstel Breakdown of academic impact, for papers by Chongxue Zhu Breakdown of academic impact, for papers by Tamio Iwamoto Breakdown of academic impact, for papers by A. Fenner Breakdown of academic impact, for papers by Kooichi Saida Breakdown of academic impact, for papers by Guihua Tu Breakdown of academic impact, for papers by V. N. Serebryakov
Rankless by CCL
2026